Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MET vs GSK✓SelectedUSD · GSKMET vs GSK performance historyLatest closeAs of-1.17%11/16
Stock and ETF performance explorer

MET vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+194.9%
GSK return
+107.3%
Excess return
+87.6%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-0.1%-1.1%-1.1%
7D-0.2%-1.3%+1.1%+0.3%
30D+1.3%+2.7%-1.5%+0.2%
3M+4.5%+2.7%+1.8%+3.1%
6M+28.7%+3.3%+25.4%+26.5%
YTD+32.0%+6.5%+25.5%+27.2%
1Y+32.5%+10.7%+21.9%+25.7%
3Y+78.3%+64.4%+13.9%+36.3%
5Y+85.7%+46.7%+39.0%+47.1%
10Y+194.9%+109.4%+85.5%+105.9%
All+194.9%+107.3%+87.6%+105.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling